Fifth anniversary of the Sex And Gender Equity in Research (SAGER) guidelines: taking stock and looking ahead

Sanne A E Peters^{1

2

3}, Thomas F Babor⁴, Robyn N Norton^{5

3}, Janine A Clayton⁶, Pavel V Ovseiko⁷, Cara Tannenbaum⁸, Shirin Heidari^{9

10}

Affiliations

¹ The George Institute for Global Health, Imperial College London, London, UK speters@georgeinstitute.org.uk.
² Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
³ The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
⁴ Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
⁵ The George Institute for Global Health, Imperial College London, London, UK.
⁶ Office of Research on Women's Health, National Institutes of Health, Bethesda, Maryland, USA.
⁷ Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
⁸ Canadian Institutes of Health Research, Institute of Gender and Health, Universite de Montreal, Montreal, Quebec, Canada.
⁹ GENDRO, Geneva, Switzerland.
¹⁰ Global Health Center, Graduate Institute of International and Development Studies, Geneva, Switzerland.

Editorial

Sanne A E Peters et al. BMJ Glob Health. 2021 Nov.

. 2021 Nov;6(11):e007853.

doi: 10.1136/bmjgh-2021-007853.

Sanne A E Peters^{1

2

3}, Thomas F Babor⁴, Robyn N Norton^{5

3}, Janine A Clayton⁶, Pavel V Ovseiko⁷, Cara Tannenbaum⁸, Shirin Heidari^{9

10}

¹ The George Institute for Global Health, Imperial College London, London, UK speters@georgeinstitute.org.uk.
² Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
³ The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
⁴ Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
⁵ The George Institute for Global Health, Imperial College London, London, UK.
⁶ Office of Research on Women's Health, National Institutes of Health, Bethesda, Maryland, USA.
⁷ Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
⁸ Canadian Institutes of Health Research, Institute of Gender and Health, Universite de Montreal, Montreal, Quebec, Canada.
⁹ GENDRO, Geneva, Switzerland.
¹⁰ Global Health Center, Graduate Institute of International and Development Studies, Geneva, Switzerland.

No abstract available

Keywords: health policies and all other topics.

Conflict of interest statement

Competing interests: None declared.

1. Heidari S, Babor TF, De Castro P, et al. . Sex and gender equity in research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev 2016;1:2. 10.1186/s41073-016-0007-6 - DOI - PMC - PubMed
1. Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, et al. . Sex and gender: modifiers of health, disease, and medicine. Lancet 2020;396:565–82. 10.1016/S0140-6736(20)31561-0 - DOI - PMC - PubMed
1. The European Association of Science Editors . The SAGER guidelines. Available: https://ease.org.uk/communities/gender-policy-committee/the-sager-guidel... [Accessed 09 Sep 2021].
1. Palmer-Ross A, Ovseiko PV, Heidari S. Inadequate reporting of COVID-19 clinical studies: a renewed rationale for the sex and gender equity in research (SAGER) guidelines. BMJ Glob Health 2021;6:e004997. 10.1136/bmjgh-2021-004997 - DOI - PMC - PubMed
1. Scott PE, Unger EF, Jenkins MR, et al. . Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs. J Am Coll Cardiol 2018;71:1960–9. 10.1016/j.jacc.2018.02.070 - DOI - PubMed